Making Swiss cohort data better findable: 2nd Call for letters of intent Making Swiss cohort data better findable: 2nd Call for letters of intent Read More »
SHFN: SWISSHEART Failure Network. (PI: Christian Matter (SPHN) & Joachim Buhmann (PHRT)) SHFN: SWISSHEART Failure Network. (PI: Christian Matter (SPHN) & Joachim Buhmann (PHRT)) Read More »
SOIN: Swiss Ophthalmic Imaging Network. (PI: Thomas Wolfensberger) SOIN: Swiss Ophthalmic Imaging Network. (PI: Thomas Wolfensberger) Read More »
IMAGINE: Radiomics for comprehensive patient and disease phenotyping in personalized health. (PI: Matthias Guckenberger) IMAGINE: Radiomics for comprehensive patient and disease phenotyping in personalized health. (PI: Matthias Guckenberger) Read More »
CREATE PRIMA: Clinical Research from multi-modality big data sources without proprietary interfaces in a multicenter approach. (PI: Joerg Leuppi) CREATE PRIMA: Clinical Research from multi-modality big data sources without proprietary interfaces in a multicenter approach. (PI: Joerg Leuppi) Read More »
SACR: The Swiss Ageing Citizen Reference. (PI: Nicole Probst-Hensch) SACR: The Swiss Ageing Citizen Reference. (PI: Nicole Probst-Hensch) Read More »
Personalized Swiss Sepsis Study: Detection and modelling of sepsis using machine learning to analyse continuous ICU monitoring, laboratory, microbiology, and -omics data for personalized sepsis management (PSSS). (PI: Adrian Egli (SPHN) & Karsten Borgwardt (PHRT)) Personalized Swiss Sepsis Study: Detection and modelling of sepsis using machine learning to analyse continuous ICU monitoring, laboratory, microbiology, and -omics data for personalized sepsis management (PSSS). (PI: Adrian Egli (SPHN) & Karsten Borgwardt (PHRT)) Read More »
Swiss Molecular Pathology Breakthrough Platform (SOCIBP). (PI: Mark Rubin (SPHN) & Gunnar Rätsch (PHRT)) Swiss Molecular Pathology Breakthrough Platform (SOCIBP). (PI: Mark Rubin (SPHN) & Gunnar Rätsch (PHRT)) Read More »
PRECISE: Identification of biomarkers and therapeutic targets in inflammatory disease immunotherapy by high-dimensional single cell analysis and cluster proteomics. (PI: Manfred Claassen (SPHN & PHRT)) PRECISE: Identification of biomarkers and therapeutic targets in inflammatory disease immunotherapy by high-dimensional single cell analysis and cluster proteomics. (PI: Manfred Claassen (SPHN & PHRT)) Read More »
